Ben Burnett Stifel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ben burnett stifel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ben Burnett Stifel Today - Breaking & Trending Today

Precigen, Inc. (PGEN) Q4 2020 Earnings Call Transcript


Operator
Good day and welcome to Precigen Fourth Quarter and Year-End 2020 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] I would now like to turn the conference over to Steve Harasym. Please go ahead.
Steven Harasym
Head of Investor Relations
Thank you, operator and thank you all for joining us today. With me are Dr. Helen Sabzevari, President and CEO of Precigen and Tom Samuelson, Head of Financial Strategy. Helen will provide an update on our pipeline and technologies after which Tom will review our fourth quarter 2020 financial results. Following the prepared remarks, we will open the call to Q&A. ....

Ben Burnett Stifel , Jason Butler , Ben Burnett , Helen Sabzevari , Justin Walshb Riley , Steve Harasym , Chuck Whitesell , Justin Walsh , Deric Joseph , Tom Samuelson , Nick Abbott , Precigen Inc , Precigen Fourth Quarter , Results Conference , Chief Executive , Trans Ova Genetics , Precigen Exemplar , Okanagan Specialty Fruits , Wells Fargo , Fargo Securities , Trans Oval , Wells Fargo Securities , பென் பர்னெட் ஸ்டிபேல் , ஜேசன் பட்லர் , பென் பர்னெட் , சக் வைட்ஸெல் ,

Nektar Therapeutics (NKTR) Q4 2020 Earnings Call Transcript


Nektar Therapeutics (NKTR) Q4 2020 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Nektar Therapeutics (NASDAQ: NKTR)
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Nektar Therapeutics Fourth Quarter 2020 Financial Results. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Ms. Jennifer Ruddock, Head of Corporate Affairs. Ma am, you may begin.
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company s SEC filings. Please see our ....

Brian Kotzin , Ben Burnett Stifel , Andy Hsieh , Gil Labrucherie , Eli Lilly , Jessica Fye , Howardw Robin , Andy Hsieh William Blair , Jay Olson Oppenheimer , Jonathan Zalevsky , Peter Lawson , Gilm Labrucherie , Jessica Fye Jpmorgan , Jay Olson , Brianl Kotzin , Ben Burnett , Difei Yang Mizuho , Paul Choi Goldman Sachs , Jennifer Ruddock , Paul Choi , Howard Robin , Steve Rosenberg , Peter Lawson Barclays , William Blair , Difei Yang , Nektar Therapeutics ,